Methacholine inhaled challenge: study of correlation among different indices expressing the result.
We tested measures of specific airway conductance (sGaw) and forced expiratory volume in one second (FEV1) versus transcutaneous oxygen tension (Ptc,O2) during inhaled methacholine bronchial challenge in 60 out-patients (38 males 22 females, mean age 33 +/- 13 yrs). The provocative doses of methacholine needed to produce a 35% decrease of sGaw (PD35,sGaw), a 20% fall in FEV1 (PD20,FEV1) and a 20% decrease in Ptc,O2 (PD20,O2) were simultaneously derived from the dose-response curves. Two groups were identified according to the PD20,FEV1 result ("responders" with a PD20,FEV1 < 2,000 micrograms methacholine and "nonresponders" with PD20,FEV1 > 2,000 micrograms methacholine). All three indices derived from the dose-response curves differed significantly between the groups (p < 0.00005). The relationship analysis showed a significantly better value for PD20,O2 versus PD35,sGaw (r = 0.98) than versus PD20, FEV1 (r = 0.62). We observed similar baseline levels and variations in arterial oxygen tension (Pa,O2) and Ptc,O2 during methacholine challenge (-25 and -27%, respectively) in 14 randomly studied responders. Thus, inhaled methacholine-induced hypoxaemia (PD20,O2) seems to reflect PD35,sGaw better than changes in FEV1. Our investigation supports the hypothesis that PD20,O2 could be useful in interpreting the methacholine inhaled challenge. It could be of help in clarifying the pathophysiological meaning of the concurrent hypoxaemia during this challenge, which should be further elucidated.
Clini
E
E
Division of Pneumology, Salvatore Maugeri Foundation IRCCS, Medical Center of Rehabilitation, Gussago, Italy.
Vitacca
M
M
Scalvini
S
S
Quadri
A
A
Foglio
K
K
D000328:Adult; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000175:diagnosis*; D001785:Blood Gas Monitoring, Transcutaneous; D001985:Bronchial Provocation Tests; D016084:Bronchoconstriction / Q000187:drug effects; D016085:Bronchoconstrictor Agents / Q000008:administration & dosage; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage
D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride